跳至主要内容
临床试验/CTRI/2015/01/005456
CTRI/2015/01/005456尚未招募未知

â??A randomized controlled trial comparing lactulose plus albumin versus lactulose alone for the treatment of hepatic encephalopathyâ??.

G B PANT HOSPITA0 个研究点目标入组 120 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age 18-80
  • Hepatic encephalopathy grade II-IV
  • Informed consent

排除标准

  • 1.Degenerative CNS disease or major psychiatric illness
  • 2. Serum creatinine > 1.5 mg/dl
  • 3. Active alcohol intake <4 weeks prior to present episode
  • 4. Others metabolic encephalopathies
  • 5. Hepatocellular Carcinoma
  • 6. Severe comorbidity such as CHF, Pulmonary disease, Neurological & Psychiatric problems impairing quality of life
  • 7. Patients who are having sensitivity to albumin or contraindication of albumin

研究者

发起方
G B PANT HOSPITA

相似试验